From Doctor Anywhere in Singapore to Doctolib in France, these ten telemedicine startups are revolutionizing virtual healthcare delivery across global markets. Here is your comprehensive guide to the companies reshaping patient care through AI-powered consultations, remote monitoring, and digital therapeutics.
The Telemedicine Revolution Accelerates in 2026
The global telemedicine market continues its remarkable expansion, projected to exceed $42 billion in 2024 with a 23.8% compound annual growth rate through 2030. Virtual healthcare delivery has evolved from pandemic necessity to permanent infrastructure, with startups across UK, Europe, Asia, and the Middle East building platforms that connect patients with physicians, specialists, and mental health professionals through smartphones and connected devices. These companies are addressing healthcare access challenges, physician shortages, and rising chronic disease prevalence through technology innovation.
1. Doctor Anywhere
Location: Singapore Founded: 2015 Funding: $180 million (Series C1) Website: doctoranywhere.com
Doctor Anywhere operates as Southeast Asia's leading tech-led healthcare platform, providing 24/7 telemedicine consultations across Singapore, Thailand, Vietnam, Malaysia, and the Philippines. The company connects patients with licensed doctors through video consultations and secure messaging, offering e-prescriptions, medication delivery, and home-based health screening services. The platform integrates mental health consultations with psychologists and specialist appointments across multiple disciplines.
The Singapore-headquartered company has raised over $180 million from investors including Novo Holdings, Asia Partners, Square Peg Capital, and IHH Healthcare. Recent partnerships with Singlife target 310,000 self-employed individuals through subscription health plans. The 2022 acquisition of Asian Healthcare Specialists expanded Doctor Anywhere into secondary care, creating a vertically integrated digital healthcare ecosystem. The company serves over one million registered users through eight physical clinics integrated with its telemedicine platform.
2. Doctolib
Location: Paris, France Founded: 2013 Funding: $267 million (Unicorn) Website: doctolib.com
Doctolib has achieved unicorn status as Europe's leading e-health platform for appointment booking and teleconsultations, valued at over $1.1 billion. The platform serves patients across France, Germany, and Italy with online booking, video consultations, and practice management tools for healthcare providers. Over 300,000 health professionals use Doctolib to manage patient appointments and deliver virtual care.
The Paris-based company has transformed healthcare access across continental Europe by eliminating scheduling friction between patients and physicians. Teleconsultation capabilities enable video visits with general practitioners and specialists, with digital prescriptions and medical records integration. Doctolib's workflow management tools help clinics optimize patient flow and reduce administrative burden. The platform's expansion into Germany and Italy positions the company as the dominant digital health infrastructure provider across major European markets.
3. TCC
Location: Hamburg, Germany Founded: 2020 Funding: €20 million (Series A, November 2024) Website: tcc.health
TCC specializes in AI-powered tele-intensive care, providing 24/7 remote ICU monitoring for hospitals across Germany and internationally. The platform manages over 3,000 hospital beds globally, enabling telemedical specialists to support bedside clinicians with real-time diagnostic assistance and treatment recommendations. Critical care physicians and nurses access patient data streams from connected monitors and devices, extending specialist expertise to facilities lacking round-the-clock intensivist coverage.
The Hamburg-based startup raised €20 million in November 2024 to expand its tele-ICU infrastructure across European healthcare systems facing intensivist shortages. TCC's AI algorithms analyze vital signs, laboratory results, and clinical observations to identify patient deterioration before critical events occur. The platform integrates with hospital information systems and medical devices from major manufacturers. Healthcare systems deploying TCC report improved patient outcomes, reduced mortality rates, and optimized resource utilization across intensive care networks.
4. Ping An Good Doctor
Location: Shanghai, China Founded: 2014 Funding: Public Company Website: pahaad.com
Ping An Good Doctor operates China's largest telemedicine platform with over 400 million registered users accessing online consultations for more than 3,000 disease categories. The platform connects patients with physicians through AI-powered triage, video consultations, and prescription services, with medications delivered through integrated pharmacy networks. The company serves as the healthcare technology arm of Ping An Insurance, one of China's largest financial conglomerates.
The Shanghai-headquartered company has driven telemedicine adoption across urban and rural Chinese markets, with 50,000 medical facilities connected to digital platforms. AI-assisted diagnostics support physicians with clinical decision tools, while the platform's symptom checker helps patients navigate appropriate care pathways. Ping An Good Doctor's scale demonstrates how telemedicine can address healthcare access challenges in markets with physician shortages and geographic barriers to specialty care.
5. Maple
Location: Toronto, Canada Founded: 2015 Funding: $85 million CAD Website: getmaple.ca
Maple has established itself as Canada's leading on-demand telemedicine platform, connecting patients with licensed doctors 24/7 through video consultations and secure messaging. The platform offers prescription writing, digital sick notes, and treatment for conditions spanning mental health, infections, allergies, sexual health, ADHD, and weight management. Integrated pharmacy partnerships enable prescription delivery directly to patients.
The Toronto-based company received a landmark $75 million CAD investment from Loblaw Companies through Shoppers Drug Mart, integrating telemedicine kiosks into 160 pharmacy locations across British Columbia. Maple's corporate wellness programs serve major employers including Unilever Canada and GlaxoSmithKline, while partnerships with insurers like Green Shield Canada provide free access for over one million plan members. The October 2024 acquisition of Beyond ADHD expanded virtual assessment and treatment services for attention deficit disorders.
6. CureApp
Location: Tokyo, Japan Founded: 2014 Funding: Series B Website: cureapp.com
CureApp pioneers digital therapeutics in Japan, developing software-based treatments that physicians prescribe as medical interventions. The company's smoking cessation application received approval as a regulated medical device, demonstrating clinical efficacy equivalent to pharmaceutical treatments. CureApp's hypertension management platform addresses Japan's aging population and chronic disease burden through smartphone-delivered behavior modification programs.
The Tokyo-based company has positioned Japan as a global leader in digital therapeutics reimbursement, with faster approval pathways than United States regulatory frameworks. Major pharmaceutical companies including Shionogi and Sumitomo Pharma have established partnerships to integrate digital therapeutics into treatment protocols. CureApp's clinical evidence from randomized controlled trials supports prescription by physicians with insurance reimbursement, creating sustainable business models for software-based healthcare interventions.
7. Cura
Location: Riyadh, Saudi Arabia Founded: 2017 Funding: $4 million (Series A) Website: cura.healthcare
Cura operates Saudi Arabia's leading telemedicine platform, providing 24/7 on-demand doctor consultations through mobile applications. The platform connects patients with over 4,500 physicians across primary care, mental health, and wellness coaching specialties, serving more than 350,000 users. Patients access consultations via video, voice, or text without appointment scheduling, with electronic prescriptions fulfilled through pharmacy networks.
The Riyadh-based company received Series A funding from Saudi Aramco's Wa'ed Ventures and Elm, reflecting Vision 2030 priorities for digital healthcare transformation. Cura's platform addresses physician access challenges across the Kingdom's geographic expanse, enabling specialty consultations for patients in remote regions. The Ministry of Health's SEHA Virtual Hospital initiative demonstrates government commitment to telemedicine infrastructure, with over nine million virtual appointments delivered in 2023.
8. Altibbi
Location: Amman, Jordan / Dubai, UAE Founded: 2008 Funding: Series B Website: altibbi.com
Altibbi has built the Middle East's largest telemedicine platform and physician community, serving patients across UAE, Saudi Arabia, Jordan, and the broader Arab world. The platform offers subscription-based live consultations through video, audio, and chat with licensed doctors, complemented by an extensive medical content library in Arabic. Over 5,000 physicians participate in the platform, providing accessible healthcare information to Arabic-speaking populations.
The company's expansion across Gulf Cooperation Council markets positions Altibbi as regional healthcare infrastructure, addressing the combination of high smartphone penetration and healthcare access challenges. Mental health services have emerged as a growth category, reducing stigma barriers through private virtual consultations. Enterprise partnerships with employers and insurers extend telemedicine benefits to employee populations, while the content platform attracts millions of monthly users seeking health information in their native language.
9. Paginemediche
Location: Naples, Italy Founded: 2000 Funding: Private Website: paginemediche.it
Paginemediche stands as Italy's leading digital healthcare platform, providing telemedicine consultations, remote patient monitoring, and digital care programs. The platform integrates with medical devices to enable comprehensive chronic disease management, connecting patients with healthcare professionals for continuous monitoring and intervention. During the COVID-19 pandemic, Paginemediche powered national pre-triage and telemonitoring services for infected patients.
The Naples-based company operates within Italy's National Recovery Plan framework, which allocates €1 billion to telemedicine infrastructure through 2025. New regulations effective January 2024 simplify patient pathways for diagnostic testing, shifting ECG and monitoring services from hospitals to pharmacies and diagnostic centers. Paginemediche's device integration capabilities position the platform for remote cardiac monitoring and chronic disease management as Italian healthcare transitions to community-based care models.
10. Qare
Location: Paris, France Founded: 2017 Funding: Series B Website: qare.fr
Qare delivers video consultations across 12 medical specialties to French patients, providing accessible virtual care through web and mobile applications. The platform connects patients with general practitioners and specialists including dermatologists, psychiatrists, pediatricians, and gynecologists, with consultations reimbursed through the French national health insurance system. Electronic prescriptions integrate with pharmacy networks for medication fulfillment.
The Paris-based company has scaled rapidly within France's regulated teleconsultation framework, which requires certification for health insurance reimbursement. Qare's specialty breadth differentiates the platform from general telemedicine services, enabling patients to access dermatology, mental health, and women's health consultations without in-person visits. The company serves both individual patients and corporate clients implementing employee wellness programs with virtual care access.
Startup Comparison Table
The following table summarizes key characteristics of these telemedicine innovators:
| Startup | Country | Founded | Funding | Focus Area | Users/Scale |
|---|---|---|---|---|---|
| Doctor Anywhere | Singapore | 2015 | $180M | Full-service telemedicine | 1M+ users |
| Doctolib | France | 2013 | $267M (Unicorn) | Booking + teleconsultation | 300K+ providers |
| TCC | Germany | 2020 | €20M | AI tele-ICU | 3,000+ beds |
| Ping An Good Doctor | China | 2014 | Public | Mass telemedicine | 400M+ users |
| Maple | Canada | 2015 | $85M CAD | On-demand virtual care | 400K+ users |
| CureApp | Japan | 2014 | Series B | Digital therapeutics | Prescription DTx |
| Cura | Saudi Arabia | 2017 | $4M | 24/7 consultations | 350K+ users |
| Altibbi | Jordan/UAE | 2008 | Series B | Arabic telemedicine | 5K+ physicians |
| Paginemediche | Italy | 2000 | Private | Remote monitoring | National scale |
| Qare | France | 2017 | Series B | Specialty teleconsultation | 12 specialties |
Investment Trends Shaping Telemedicine in 2026
Early-stage funding continues to dominate telemedicine investment, representing 72% of all deals as entrepreneurs identify underserved specialties and geographies. AI-enabled companies attract one in three digital health investment dollars, with applications spanning clinical decision support, diagnostic assistance, and administrative automation. Mental health platforms demonstrate particular momentum as virtual delivery reduces access barriers and stigma.
Regulatory frameworks have matured across major markets, with Germany's Digital Health Applications pathway enabling prescription and reimbursement for 69 approved apps. France's teleconsultation certification requirements create quality standards while enabling insurance coverage. Saudi Arabia's Vision 2030 and Japan's Healthcare Policy 2025 initiatives prioritize digital transformation with substantial government investment.
The telemedicine startups positioned for success in 2026 combine clinical excellence with technology innovation, addressing specific patient populations and care pathways rather than competing as undifferentiated consultation platforms. Whether focused on intensive care in Germany, digital therapeutics in Japan, or Arabic-speaking populations across the Middle East, these companies demonstrate that localized solutions built on global technology can transform healthcare delivery at scale.